| Identification | Back Directory | [Name]
AT 1015 | [CAS]
190508-50-0 | [Synonyms]
AT 1015
AT-1015 HCl
AT-1015 HCl anhydrous
N-[2-[4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl]ethyl]-1-formyl-4-piperidinecarboxamide hydrochloride | [Molecular Formula]
C29H34ClN3O2 | [MOL File]
190508-50-0.mol | [Molecular Weight]
492.06 |
| Hazard Information | Back Directory | [Uses]
AT 1015 is a potent 5-HT2A receptor antagonist, which also shows antithrombotic activity in a in rat arterial thrombosis model. AT-1015 is a potent and long-acting oral antithrombotic agent in this model. | [Biological Activity]
at 1015 is a potent antagonist of 5-ht2a receptor [1].the 5-ht2a receptor is a g protein-coupled receptor and a subtype of the 5-ht2 receptor, which belongs to the serotonin receptor family. the 5-ht2a receptor plays an important role in clathrin mediated endocytosis of jc virus, the human polyoma virus which causes progressive multifocal leukoencephalopathy (pml).at 1015 is a potent 5-ht2a receptor antagonist. at 1015 bound to 5-ht2 receptors in rabbit cerebral cortex membrane with pki value of 7.94 [1].in a photochemically induced rat femoral arterial thrombosis (pit) model, at 1015 (1 mg/kg) significantly inhibited vascular contraction induced by 5-ht and prolonged the time for 24 h that required to occlusion of the artery in a dose-dependent way. while, at 1015 (10 mg/kg) didn’t prolong bleeding time in the tail transection bleeding time test [2]. at 1015 inhibited 5-ht2a receptor-mediated platelet aggregation both in vitro and in rat. in the rat peripheral vascular lesion model, at 1015 (1 mg/kg) significantly inhibited progression of peripheral vascular lesions [3]. | [References]
[1]. rashid m, watanabe m, nakazawa m, et al. assessment of affinity and dissociation ability of a newly synthesized 5-ht2 antagonist, at-1015: comparison with other 5-ht2 antagonists. jpn j pharmacol, 2001, 87(3): 189-194.
[2]. kihara h, koganei h, hirose k, et al. antithrombotic activity of at-1015, a potent 5-ht(2a) receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time. eur j pharmacol, 2001, 433(2-3): 157-162.
[3]. kihara h, hirose k, koganei h, et al. at-1015, a novel serotonin (5-ht)2 receptor antagonist, blocks vascular and platelet 5-ht2a receptors and prevents the laurate-induced peripheral vascular lesion in rats. j cardiovasc pharmacol, 2000, 35(4): 523-530. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
InvivoChem
|
| Tel: |
13549236410 |
| Website: |
https://www.invivochem.cn/ |
|